In this contributed article, Sarah Schinckel, director of emerging technologies in the Intelligent Solutions Group (ISG) at John Deere, discusses how AI is being harnessed in agriculture. The piece also offers considerations for leaders as AI is integrated across industries.
How Real-Time Data Analytics and AI Are Transforming Heavy Equipment Operations
In this contributed article, freelance writer Ellie Gabel discusses how real-time data analysis and AI are refining various aspects of the heavy equipment industry, further promoting seamlessness and automation. Take a look at some of the ways data analytics and AI are transforming the sector.
How Generative AI is Shaping the Next Wave of Innovation
In this contributed article, Harikrishna Kundariya, co-founder, Director of eSparkBiz Technologies, discusses how generative AI is emerging as a revolutionary technology that is simplifying as well as reducing the cost of doing business across sectors. Generative AI is the new innovation after the Industrial Revolution that is going to bring remarkable changes in every aspect of the overall business environment.
Wealth Management Firms Expected to More Than Double AI Budgets
Wipro Limited, a leading technology services and consulting company, unveiled insights from its report, “AI in Wealth Management: Navigating an Evolving Data-Driven Landscape.” The report, based on a survey conducted among 100 executives in the U.S., examines how artificial intelligence (AI) is changing the wealth management landscape and emphasizes the importance of strategic investments in technology infrastructure.
Zingly Announces a Proven, Safe-AI Solution for Banks and Financial Institutions to Drive Revenue Growth with Cost Reduction
AI-driven platform helps financial institutions deliver personalized experiences to maximize customer acquisition, onboarding and wallet share in regulated environments Zingly.ai, the GenAI and digital-first CX Center provider, unveiled a suite of AI solutions to fuel revenue growth for banking, financial services and insurance (BFSI) institutions. These companies face increasingly complex customer inquiries, heightened expectations and pressure to […]
UiPath Integrates Anthropic Claude Language Models to Deliver Next Generation AI Assistant and Solutions
UiPath embeds Anthropic’s Claude LLMs to fuel UiPath Autopilot for everyone, Clipboard AI, and a new GenAI healthcare solution to offer customers improved productivity, cost savings, and decision-making capabilities UiPath (NYSE: PATH), a leading enterprise automation and AI software company, announced the integration of Anthropic’s large language model (LLM), Claude 3.5 Sonnet, to deliver new AI features in three key […]
Relyance AI Raises $32 Million Series B Funding to Safeguard AI Innovation in the Enterprise
Relyance AI, a leading AI-powered data governance platform that provides complete visibility and control over enterprise-wide data, announced a $32.1 million Series B funding round to scale operations and meet the needs of the exploding use of artificial intelligence in the enterprise.
AI’s Role in Revolutionizing Anti-Money Laundering Efforts
In this contributed article, Vall Herard, CEO of Saifr.ai, points out that by augmenting human expertise with machine precision, AI is dramatically boosting the efficacy, efficiency, and scale of AML and KYC solutions.
Dataiku Launches LLM Guard Services to Control Generative AI Rollouts From Proof-of-Concept to Production in the Enterprise
Dataiku, the Universal AI Platform, today announced the launch of its LLM Guard Services suite that is designed to advance enterprise GenAI deployments at scale from proof-of-concept to full production without compromising cost, quality, or safety.
Proscia Launches Concentriq Embeddings and Developer Toolkit to Unleash Pathology AI Development
Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, today announced the launch of Concentriq® Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics.